Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-21-071793
Filing Date
2021-05-25
Accepted
2021-05-25 16:12:32
Documents
1
Period of Report
2021-05-24

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2117446-2_4seq1.html 4  
1 OWNERSHIP DOCUMENT tm2117446-2_4seq1.xml 4 4340
  Complete submission text file 0001104659-21-071793.txt   5957
Mailing Address 700 TECHNOLOGY DRIVE PITTSBURGH PA 15219
Business Address 700 TECHNOLOGY DRIVE PITTSBURGH PA 15219 6464501790
NeuBase Therapeutics, Inc. (Issuer) CIK: 0001173281 (see all company filings)

EIN.: 465622433 | State of Incorp.: DE | Fiscal Year End: 0930
SIC: 2834 Pharmaceutical Preparations

Mailing Address 350 TECHNOLOGY DRIVE PITTSBURGH PA 15219
Business Address
Motesharei Kianoush (Reporting) CIK: 0001863927 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35963 | Film No.: 21960741